Foscarnet Sodium

CAS 63585-09-1 8 current records 1 historicalSmall Molecule

Who holds supplier records for Foscarnet Sodium? 8 organisations hold a current record for Foscarnet Sodium: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), China (2), France (1) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Foscarnet Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/foscarnet-sodium

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Foscarnet Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Foscarnet Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Foscarnet Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. LianyungangCN
CEP 2017-137 - Rev 01
Foscarnet sodium hexahydrate
Jul 2025—
EMCURE PHARMACEUTICALS LIMITED PuneIN
CEP 2021-342 - Rev 02
Foscarnet sodium hexahydrate
Jun 2025Inspected May 2023
Hungary, outside 3-year window
Chemwerth, Inc. WoodbridgeUS
R0-CEP 2020-337 - Rev 00
Foscarnet sodium hexahydrate
Feb 2023—
MAITHRI DRUGS PRIVATE LIMITED Bonthapally VillageIN
R0-CEP 2020-218 - Rev 00
Foscarnet sodium hexahydrate
May 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Foscarnet Sodium are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • JIANGSU TIANQING PHARMACEUTICAL FACTORY
    Inactive DMF 11385 · filed Mar 1995

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Foscarnet Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL754).

Chemical identity

IUPAC name
trisodium;phosphonatoformate
Canonical SMILES
C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+]
InChIKey
DFHAXXVZCFXGOQ-UHFFFAOYSA-K
Synonyms
A-29622, EHB 776, EHB-776, Foscarnet de sodio, Foscarnet sodique, Foscarnet sodium, Foscarnet sodium anhydrous, Foscarnet sodium hexahydrate, Foscarnet sodium hydrate, Foscarnet trisodium hexahydrate, Foscavir, NSC-313410

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Pyrophosphate Analog DNA Polymerase Inhibitor
Mechanism of action
Chelating Activity; DNA Polymerase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Foscarnet Sodium?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Foscarnet Sodium: Emcure Pharmaceuticals Limited (India), LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (China), MAITHRI DRUGS PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Beijing Sciecure Pharmaceutical Co., Ltd. (China), CHEMWERTH INC (France), GLAND PHARMA LTD (India) and TRIFARMA SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Foscarnet Sodium Drug Master Files are active?

Emcure Pharmaceuticals Limited (DMF 32652), LIANYUNGANG RUNZHONG PHARMACEUTICAL CO LTD (DMF 29056), MAITHRI DRUGS PRIVATE LTD (DMF 34968), APITORIA PHARMA PRIVATE LTD (DMF 35025), Beijing Sciecure Pharmaceutical Co., Ltd. (DMF 33288), CHEMWERTH INC (DMF 28996), GLAND PHARMA LTD (DMF 29814) and TRIFARMA SPA (DMF 19085). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Foscarnet Sodium records mean?

1 organisation has only inactive Type II DMFs for Foscarnet Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Foscarnet Sodium have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Foscarnet Sodium on the EDQM register, including LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD. Lianyungang (CN), EMCURE PHARMACEUTICALS LIMITED Pune (IN), Chemwerth, Inc. Woodbridge (US) and MAITHRI DRUGS PRIVATE LIMITED Bonthapally Village (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Foscarnet Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Foscarnet Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.